title: Selected topics of the 4th International Cooperative Study Group meeting on immune thrombocytopenia revisited.
abstract: The Intercontinental Cooperative immune thrombocytopenia (ITP) Study Group (ICIS) held its 4th Expert Meeting in September 2012 in Montreux, Switzerland. The program reunited researchers and clinicians from all over the globe and was organized with lectures and seminars for real-time exchange of latest information. Platelets target victims of autoimmune disease on their own, participating under physiological conditions in the immune network; these small cells are more immunologically savvy than previously thought. Currently, researchers focus their attention on regulatory T and regulatory B cells, ie, cells that might have a decisive impact on how ITP spontaneously resolves or evolves into chronic disease. Diagnostic criteria and prognosis are increasingly benefiting from molecular biological tests, and therapy has evolved with the availability of biosimilar agents and recombinant hormones or blockers of their receptors.
authors.affiliation: University of Bern, Bern, Switzerland. nyu@lmz-risch.ch
authors.forename: Urs E
authors.initials: UE
authors.lastname: Nydegger
authors.forename: Lorenz
authors.initials: L
authors.lastname: Risch
mesh_terms: D000818:Animals; D006801:Humans; D051379:Mice; D013921:Thrombocytopenia / Q000097:blood / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology / Q000628:therapy